NCT02439008 2026-03-13
Early Biomarkers of Tumor Response in High Dose Hypofractionated Radiotherapy Word Package 3 : Immune Response
Centre Oscar Lambret
Phase NA Terminated
Clinical Trials
43 trialsNCT04258566 2026-02-02
Electromagnetic Tracking and Optical Imaging With ICG for Hepatic Biopsies
National Institutes of Health Clinical Center (CC)
Phase NA Terminated
NCT02881554 2025-10-29
Sulfur Colloid SPECT/CT in Measuring Liver Function in Patients With Primary or Metastatic Liver Cancer Undergoing Radiation Therapy or Surgery
University of Washington
Phase NA Terminated
NCT06302400 2025-09-19
RHEPaiR
Imperial College London
Phase NA Terminated
NCT05582018 2025-09-15
PANORAMA
Techsomed Medical Technologies LTD
Phase NA Terminated
NCT05451862 2025-08-26
HOMIE-166
Terumo Europe N.V.
Phase NA Terminated
NCT04520906 2025-07-01
To Evaluate the Safety and Efficacy of Microwave Ablation Therapy in Patients With Primary Liver Cancer
Suzhou Hengruihongyuan Medical Technology Co. LTD
Phase NA Terminated
NCT03534141 2025-05-16
MHALT
University of California, San Francisco
Phase NA Terminated
NCT03889093 2025-03-24
Radioembolization of Primary and Secondary Liver Malignancies and The Effect On The Immune System
University of Minnesota
Phase NA Terminated
NCT03812289 2025-03-07
Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer
OHSU Knight Cancer Institute
Phase NA Terminated
NCT03397342 2024-01-18
MRI Only Radiation Therapy With CPAP
Albert Einstein College of Medicine
Phase NA Terminated
NCT02802124 2023-12-07
Carbon Ion Radiotherapy for the Treatment of Chinese Hepatocellular Carcinoma
Shanghai Proton and Heavy Ion Center
Phase NA Terminated
NCT04235660 2023-10-25
SBRT vs Y90
Indiana University
Phase NA Terminated
NCT02847468 2023-10-11
PREMETHEP
Centre Georges Francois Leclerc
Phase NA Terminated
NCT03662841 2023-05-03
Ablative Chemoembolization for Unresectable and Large Hepatocellular Carcinoma
Chinese University of Hong Kong
Phase NA Terminated
NCT03808766 2023-05-03
A Study on the Angioarchitecture of Hepatocellular Carcinoma
Chinese University of Hong Kong
Phase NA Terminated
NCT04649671 2023-03-06
The Effect of Mobile Health-based Exercise on Hepatocellular Carcinoma Patients With Insulin Resistance
Samsung Medical Center
Phase NA Terminated
NCT04077372 2023-01-27
Assessment of a Serious Illness Conversation Guide (SICG) in Advanced Gastro-Intestinal Cancers
Stanford University
Phase NA Terminated
NCT01167374 2022-11-03
PROMETHEUS-01
University Hospital Heidelberg
Phase NA Terminated
NCT02446925 2022-07-28
Surefire Catheter Versus Standard End-hole Microcatheter: A Pilot Study
Wright State University
Phase NA Terminated
NCT03402607 2022-07-08
PROVE-HCC
Duke University
Phase NA Terminated
NCT03956940 2022-06-21
HELP
Institut du Cancer de Montpellier - Val d'Aurelle
Phase NA Terminated
NCT02704130 2022-04-22
TAE and MWA Combination Therapy in Early-stage Hepatocellular Carcinoma
Wake Forest University Health Sciences
Phase NA Terminated
NCT03979547 2022-03-09
EXALT
Milton S. Hershey Medical Center
Phase NA Terminated
NCT01141478 2021-10-15
HCC
Loma Linda University
Phase NA Terminated
NCT00503867 2020-12-10
SIR-Spheres® for the Treatment of Unresectable Hepatocellular Carcinoma
Sirtex Medical
Phase NA Terminated
NCT01486134 2020-05-13
ARMTICH
Assistance Publique - Hôpitaux de Paris
Phase NA Terminated
NCT02323360 2019-10-25
A Trial on SBRT After Incomplete TAE or TACE Versus Exclusive TAE or TACE For Treatment of Inoperable HCC
Istituto Clinico Humanitas
Phase NA Terminated
NCT02147301 2019-09-10
TACE Using Doxorubicin-eluting Beads for Patients With HCC and Marginal Hepatic Reserve
University of California, San Francisco
Phase NA Terminated
NCT01817205 2019-08-30
Combined Chemoembolization and Systemic Hyperthermia for Unresectable Hepatocellular Carcinoma
Chinese University of Hong Kong
Phase NA Terminated
NCT01290523 2019-05-13
Yttrium-90 Radioembolization With Glass Microspheres (TheraSphere) for Patients With Hepatocellular Carcinoma
University of California, San Francisco
Phase NA Terminated
NCT02748304 2019-02-15
Sorafenib Combined With Aspirin to Prevent the Recurrence in High-risk Patients With Hepatocellular Carcinoma
Fudan University
Phase NA Terminated
NCT02057874 2018-07-11
3-Tesla MRI Response to TACE in HCC (Liver Cancer)
Vanderbilt-Ingram Cancer Center
Phase NA Terminated
NCT02748161 2018-06-21
QED
SurefireMedical
Phase NA Terminated
NCT01259024 2018-05-15
The LC Bead Trial; Transarterial Chemoembolization of Hepatocellular Carcinoma (HCC)With a Drug-eluting Bead
Washington University School of Medicine
Phase NA Terminated
NCT02585687 2017-09-01
ETAFIRM
Hospices Civils de Lyon
Phase NA Terminated
NCT01005875 2017-05-10
RAD 0901
University of Alabama at Birmingham
Phase NA Terminated
NCT02527577 2015-08-19
BLOC-TAP
Centre Hospitalier Universitaire de Saint Etienne
Phase NA Terminated
NCT02482909 2015-06-26
A Study Comparing Radiofrequency Ablation and Hepatic Resection for Hepatocellular Carcinoma
Seoul National University Hospital
Phase NA Terminated
NCT00763776 2014-02-27
SECCI
Assistance Publique - Hôpitaux de Paris
Phase NA Terminated
NCT00087191 2013-01-16
EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer
National Cancer Institute (NCI)
Phase NA Terminated
NCT00469963 2012-09-03
Internal Radiation Therapy in Treating Patients With Primary Liver Cancer That Cannot Be Removed by Surgery
Vanderbilt-Ingram Cancer Center
Phase NA Terminated
NCT01197820 2012-06-14
THeR-IRM
University Hospital, Bordeaux
Phase NA Terminated